Conclusion
Approximately one-third patients used opioids before lumbar arthrodesis. Postoperative opioid use fell dramatically during the first 3 months in ON patients, but nearly half of the pre-op OUs will remain on narcotics at 1 year after lumbar arthrodesis. Preoperative narcotic consumption, comorbidities, and drug/alcohol abuse were major drivers of prolonged postoperative narcotic use following lumbar arthrodesis. The identified risk factors and the proposed clinical utility app can be used as an adjunct to risk-stratification, patient counseling for encouraging discontinuation of presurgical narcotic use, and opioid weaning strategies. In addition, our data including the online calculator will serve as a baseline for future comparison as the national societies work to implement strategies for safer and more effective pain management control to mitigate opioid abuse.
A portion of the work was submitted as an abstract to the 11th Annual meeting of the Lumbar Spine Research Society (LSRS), Chicago, IL, and was presented as a podium presentation.
The device(s)/drug(s) is/are FDA-approved or approved by corresponding national agency for this indication.
No funds were received in support of this work.
No relevant financial activities outside the submitted work.
Spine. 2018;43(17):1208-1216. © 2018 Lippincott Williams & Wilkins
Comments